Virtual reality could ease symptoms during intensive blood cancer treatment
NCT ID NCT07649512
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using a virtual reality headset for guided muscle relaxation can help people undergoing cell therapies like CAR-T or stem cell transplant feel better. Participants will use the VR headset once daily for up to 20 minutes during their hospital stay. Researchers will measure how practical this approach is and whether it improves symptoms like pain, anxiety, and fatigue.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Progressive Muscle Relaxation delivered via Virtual Reality
- What this could lead to
- If it works, this could offer a drug-free way to reduce anxiety, pain, and other symptoms during intensive cancer therapy.
- What could go wrong
- This is a small feasibility study, so it may not prove whether VR relaxation actually improves symptoms. The effect may be limited by patients' ability to use the headset.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEME MALIGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Arizona
Tucson, Arizona, 85719, United States